COMBINATION PHARMACEUTICAL AGENTS AS RSV INHIBITORS
The present invention relates to pharmaceutical agents administered to a subject either in combination or in series for the treatment of a Respiratory Syncytial Virus (RSV) infection, wherein treatment comprises administering a compound effective to inhibit the function of the RSV and an additional compound or combinations of compounds having anti-RSV activity.
-
Page/Page column 161
(2019/04/26)
BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
-
Page/Page column 166; 167
(2017/02/09)
COMPOUNDS ACTIVE TOWARDS BROMODOMAINS
Disclosed are compounds towards bromodomains, pharmaceutical compositions containing the compounds and use of the compounds in therapy.
-
Page/Page column 318; 319
(2016/05/02)
More Articles about upstream products of 1017783-03-7